Comparison of remission criteria in a tumour necrosis factor inhibitor treated rheumatoid arthritis longitudinal cohort: patient global health is a confounder-Reference-Cited by-同舟云学术

Comparison of remission criteria in a tumour necrosis factor inhibitor treated rheumatoid arthritis longitudinal cohort: patient global health is a confounder

Published:2013 Issue:6 Volume:15 Page:R221
ISSN:1478-6354
Container-title:Arthritis Research & Therapy
language:en
Short-container-title:Arthritis Res Ther

Author:

Balogh Emese,Dias Joao,Orr Carl,Mullan Ronan,Harty Len,FitzGerald Oliver,Gallagher Phil,Molloy Miriam,O’Flynn Eileen,Kelly Alexia,Minnock Patricia,O’Neill Madeline,Moore Louise,Murray Mairead,Fearon Ursula,Veale Douglas J

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the effects of baricitinib and tocilizumab on disease activity in patients with rheumatoid arthritis: a propensity score matching analysis;Clinical Rheumatology;2021-06-16

2. POS0206 DESIGN AND CHARACTERISATION OF A THERAPEUTIC BISPECIFIC TANDEM scFv-Fc FUSION PROTEIN WITH ANTI-TNF AND SYNOVIUM-TARGETING SPECIFICITY FOR THE TREATMENT OF RHEUMATOID ARTHRITIS;Annals of the Rheumatic Diseases;2021-05-19

3. Long-term remission and biologic persistence rates: 12-year real-world data;Arthritis Research & Therapy;2021-01-13

4. Limiting factors to Boolean remission differ between autoantibody-positive and -negative patients in early rheumatoid arthritis;Therapeutic Advances in Musculoskeletal Disease;2021-01

5. Clinical predictors of multiple failure to biological therapy in patients with rheumatoid arthritis;Arthritis Research & Therapy;2020-12